Prostate News Archive
21-Jan-2008
Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend (EurekAlert!)
Dr. Yair Lotan's analytical research calls for men to weigh the potential benefits and as well as the side effects of the drug finasteride before taking it to prevent prostate... A Phase II Clinical Trial Of Sorafenib In Androgen-Independent Prostate Cancer (Medical News Today)
UroToday.com- In the January 1, 2008 issue of Clinical Cancer Research, Dr. Dahut and colleagues report a Phase II trial of Sorafenib in androgen-independent prostate cancer (AICaP). Sorafenib is an oral, multikinase inhibitor targeting Raf kinase, vascular endothelial growth factor receptor, platelet-derived growth factor receptor, c-kit, and c-Ret. Pros, Cons of Drug Proven to Prevent Prostate Cancer Should be Considered, Researchers Recommend (Newswise)
Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
Back to Prostate News Archive
